Eventually, the relation between SLC2A1 and CRC tumor ferroptosis, immunofiltration, m6A modification, and ceRNA network was investigated, which provides a basis for the development of new therapeutic strategies. Here, SLC2A1 is linked to colorectal carcinoma.